Compile Data Set for Download or QSAR
Report error Found 549 Enz. Inhib. hit(s) with all data for entry = 10309
TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526754BDBM526754(US11186577, Cmpd. No. 109)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526755BDBM526755(US11186577, Cmpd. No. 110)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526863BDBM526863(US11186577, Cmpd. No. 204B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526756BDBM526756(US11186577, Cmpd. No. 111)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526757BDBM526757(US11186577, Cmpd. No. 112)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526758BDBM526758(US11186577, Cmpd. No. 113)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526865BDBM526865(US11186577, Cmpd. No. 205B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526759BDBM526759(US11186577, Cmpd. No. 114)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526760BDBM526760(US11186577, Cmpd. No. 115)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526761BDBM526761(US11186577, Cmpd. No. 116)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526867BDBM526867(US11186577, Cmpd. No. 206B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526762BDBM526762(US11186577, Cmpd. No. 122)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526746BDBM526746(US11186577, Cmpd. No. 92)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526857BDBM526857(US11186577, Cmpd. No. 201B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526747BDBM526747(US11186577, Cmpd. No. 93)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526748BDBM526748(US11186577, Cmpd. No. 94)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526859BDBM526859(US11186577, Cmpd. No. 202B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526749BDBM526749(US11186577, Cmpd. No. 95)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526750BDBM526750(US11186577, Cmpd. No. 96)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526751BDBM526751(US11186577, Cmpd. No. 97)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526752BDBM526752(US11186577, Cmpd. No. 107)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526861BDBM526861(US11186577, Cmpd. No. 203B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526753BDBM526753(US11186577, Cmpd. No. 108)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526880BDBM526880(US11186577, Cmpd. No. 228)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526769BDBM526769(US11186577, Cmpd. No. 138)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526879BDBM526879(US11186577, Cmpd. No. 227)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526881BDBM526881(US11186577, Cmpd. No. 229)
Affinity DataIC50: 100nMAssay Description:The purpose of the assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin receptor 2. The assay was performed in co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526770BDBM526770(US11186577, Cmpd. No. 142B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526881BDBM526881(US11186577, Cmpd. No. 229)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526882BDBM526882(US11186577, Cmpd. No. 230)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526884BDBM526884(US11186577, Cmpd. No. 232)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526770BDBM526770(US11186577, Cmpd. No. 142B | US11186577, Cmpd. No....)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526885BDBM526885(US11186577, Cmpd. No. 233)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526888BDBM526888(US11186577, Cmpd. No. 236)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526887BDBM526887(US11186577, Cmpd. No. 235)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526890BDBM526890(US11186577, Cmpd. No. 238)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526889BDBM526889(US11186577, Cmpd. No. 237)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526892BDBM526892(US11186577, Cmpd. No. 240)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526773BDBM526773(US11186577, Cmpd. No. 147)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526774BDBM526774(US11186577, Cmpd. No. 153)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526870BDBM526870(US11186577, Cmpd. No. 218)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526764BDBM526764(US11186577, Cmpd. No. 125)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526869BDBM526869(US11186577, Cmpd. No. 217)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526872BDBM526872(US11186577, Cmpd. No. 220)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526871BDBM526871(US11186577, Cmpd. No. 219)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526766BDBM526766(US11186577, Cmpd. No. 134)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526874BDBM526874(US11186577, Cmpd. No. 222)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526873BDBM526873(US11186577, Cmpd. No. 221)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526875BDBM526875(US11186577, Cmpd. No. 223)
Affinity DataIC50: 100nMAssay Description:The purpose of the assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin receptor 2. The assay was performed in co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 526875BDBM526875(US11186577, Cmpd. No. 223)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

Displayed 1 to 50 (of 549 total ) | Next | Last >>
Jump to: